Singapore approved the Moderna (NASDAQ: MRNA) vaccine last week, marking another key milestone for the biotechnology company.
But Moderna was not the only company that deserves some credit.
The biotech firm had a huge helping hand from Veeva Systems (NASDAQ: VEEV), a software-as-a-service (SaaS) provider.
As the pandemic spread around the world,...
Everyone has their own preferred way of investing.
For All Stars, our clear preference is for growth.
We all have our own reasons why we invest the way we do.
Investors looking for value plays find comfort in paying a lower price. Income investors, on the other hand,...
Every week, there is a stock out there hitting its 52-week low.
In other words, there is no shortage of cheap stocks. These are not hard to find.
But low prices alone do not make a stock worth buying.
Ideally, the company behind that stock should exhibit all...
If you haven’t heard of remdesivir, an antiviral drug, you will soon.
Remdesivir is one of the most promising treatments for COVID-19 that is undergoing trial testing.
In fact, shares of the drug’s maker, Gilead Sciences (NASDAQ: GILD), surged close to 10% on 17th April when initial...